Phase 2 EGFR Mutation Clinical Trials

6 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–6 of 6 trials

Recruiting

Phase 1Phase 2

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

HER2 MutationAdvanced Non-Small Cell Lung CancerEGFR Mutation

Bayer400 enrolled94 locationsNCT05099172

Recruiting

Phase 2

ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs

NSCLC (Advanced Non-small Cell Lung Cancer)EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer

Fudan University53 enrolled1 locationNCT06775743

Recruiting

Phase 1Phase 2

A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer

EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer

Wayshine Biopharm, Inc.100 enrolled12 locationsNCT06631989

Recruiting

Phase 2

A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib

Non-Small Cell Lung Cancer With EGFR Mutation

Abbisko Therapeutics Co, Ltd54 enrolled5 locationsNCT06668103

Recruiting

Phase 2

Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study

Non-small Cell Lung Cancer (NSCLC)Leptomeningeal MetastasesBrain Metastases+2 more

Li-kun Chen70 enrolled1 locationNCT06728865

Recruiting

Phase 1Phase 2

A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation

Suzhou Genhouse Bio Co., Ltd.94 enrolled6 locationsNCT06306456